• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物与非酒精性脂肪性肝病

Natural Products on Nonalcoholic Fatty Liver Disease.

作者信息

Xu Jiao-Ya, Zhang Li, Li Zhong-Ping, Ji Guang

机构信息

Institute of Digestive Disease Shanghai University of Traditional Chinese Medicine, 725 south Wanping Road, Shanghai 200032, China.

出版信息

Curr Drug Targets. 2015;16(12):1347-55. doi: 10.2174/1389450116666150531155711.

DOI:10.2174/1389450116666150531155711
PMID:26028044
Abstract

Non-alcoholic fatty liver disease (NAFLD) is a chronic disorder of lipid and carbohydrate metabolism and is often associated with endoplasmic reticulum stress, energy homeostasis dysregulation, and inflammation at cellular and molecular levels. Use of currently available anti-hyperlipidemia, hypoglycemia, or anti-inflammation drugs to treat NAFLD has not achieved desirable outcomes. A growing attention thus has been paid towards natural products as an alternative means in treating NALFD. Some of the natural products apparently possess the properties of ameliorating symptoms of NAFLD through restoration of lipid and carbohydrate metabolism and energy homeostasis. Data from recent animal and human studies concerning the use of natural products in the treatment of NAFLD are analyzed, and the potential underlying mechanisms are discussed.

摘要

非酒精性脂肪性肝病(NAFLD)是一种脂质和碳水化合物代谢的慢性紊乱疾病,常与内质网应激、能量稳态失调以及细胞和分子水平的炎症相关。使用目前可用的抗高脂血症、低血糖或抗炎药物治疗NAFLD尚未取得理想效果。因此,天然产物作为治疗NAFLD的替代手段越来越受到关注。一些天然产物显然具有通过恢复脂质和碳水化合物代谢以及能量稳态来改善NAFLD症状的特性。本文分析了近期关于使用天然产物治疗NAFLD的动物和人体研究数据,并讨论了潜在的作用机制。

相似文献

1
Natural Products on Nonalcoholic Fatty Liver Disease.天然产物与非酒精性脂肪性肝病
Curr Drug Targets. 2015;16(12):1347-55. doi: 10.2174/1389450116666150531155711.
2
Hepatic AMP Kinase as a Potential Target for Treating Nonalcoholic Fatty Liver Disease: Evidence from Studies of Natural Products.肝脏AMP激酶作为治疗非酒精性脂肪性肝病的潜在靶点:来自天然产物研究的证据
Curr Med Chem. 2018;25(8):889-907. doi: 10.2174/0929867324666170404142450.
3
Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.白杨素通过改善氧化应激、炎症反应和脂代谢改善高脂饮食诱导的非酒精性脂肪性肝病(NAFLD)。
Biomed Pharmacother. 2018 Jan;97:1397-1408. doi: 10.1016/j.biopha.2017.10.035. Epub 2017 Dec 14.
4
Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease.传统中草药提取物诱导自噬作为非酒精性脂肪性肝病治疗的新方法。
World J Gastroenterol. 2017 Mar 21;23(11):1964-1973. doi: 10.3748/wjg.v23.i11.1964.
5
Exploring the mechanism of PingTang No.5 capsule on nonalcoholic fatty liver disease through network pharmacology and experimental validation.通过网络药理学和实验验证探索平糖 5 号胶囊治疗非酒精性脂肪性肝病的作用机制。
Biomed Pharmacother. 2021 Jun;138:111408. doi: 10.1016/j.biopha.2021.111408. Epub 2021 Mar 5.
6
GLP-1 receptor agonists: effects on the progression of non-alcoholic fatty liver disease.GLP-1 受体激动剂:对非酒精性脂肪性肝病进展的影响。
Diabetes Metab Res Rev. 2015 May;31(4):329-35. doi: 10.1002/dmrr.2580. Epub 2014 Sep 14.
7
Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease.内质网与线粒体在非酒精性脂肪肝病中的相互作用。
Lipids Health Dis. 2020 Apr 13;19(1):72. doi: 10.1186/s12944-020-01210-0.
8
Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.黄连素改善非酒精性脂肪性肝病中的糖异生和脂质代谢。
BMC Endocr Disord. 2017 Feb 28;17(1):13. doi: 10.1186/s12902-017-0165-7.
9
Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment.非酒精性脂肪性肝病(NAFLD)发病机制及天然产物的防治。
Int J Mol Sci. 2022 Dec 7;23(24):15489. doi: 10.3390/ijms232415489.
10
Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress.白花丹素通过调节脂质代谢、炎症和氧化应激减轻果糖诱导的大鼠肥胖和非酒精性脂肪肝疾病。
Biomed Pharmacother. 2019 Mar;111:686-694. doi: 10.1016/j.biopha.2018.12.139. Epub 2019 Jan 3.

引用本文的文献

1
Bridging the Gap: Exploring the Preclinical Potential of in Metabolic-Associated Fatty Liver Disease.弥合差距:探索[具体内容]在代谢相关脂肪性肝病中的临床前潜力。 (原文中“in Metabolic-Associated Fatty Liver Disease”前缺少具体内容)
Evid Based Complement Alternat Med. 2023 Nov 9;2023:8840427. doi: 10.1155/2023/8840427. eCollection 2023.
2
Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates.天然化合物对抗非酒精性脂肪性肝病(NAFLD):建议候选物的优缺点。
Int J Mol Sci. 2022 Mar 2;23(5):2764. doi: 10.3390/ijms23052764.
3
Ethanol Extract of Root Attenuates Non-Alcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice via Regulation of Lipogenesis and Lipid Uptake.
根的乙醇提取物通过调节脂肪生成和脂质摄取来减轻高脂饮食诱导肥胖小鼠的非酒精性脂肪肝疾病。
Nutrients. 2021 Sep 24;13(10):3338. doi: 10.3390/nu13103338.
4
Regulation of Mitochondrial Function by Natural Products for the Treatment of Metabolic Associated Fatty Liver Disease.天然产物对线粒体功能的调控在代谢相关性脂肪性肝病治疗中的作用。
Can J Gastroenterol Hepatol. 2021 Jun 16;2021:5527315. doi: 10.1155/2021/5527315. eCollection 2021.
5
Diphlorethohydroxycarmalol Attenuates Palmitate-Induced Hepatic Lipogenesis and Inflammation.二氢二羟基卡瓦胡椒醇可减轻软脂酸诱导的肝脏脂肪生成和炎症。
Mar Drugs. 2020 Sep 18;18(9):475. doi: 10.3390/md18090475.
6
Improvement in Menopause-Associated Hepatic Lipid Metabolic Disorders by Herbal Formula HPC03 on Ovariectomized Rats.中药复方HPC03对去卵巢大鼠绝经相关肝脏脂质代谢紊乱的改善作用
Evid Based Complement Alternat Med. 2020 Jul 19;2020:1409376. doi: 10.1155/2020/1409376. eCollection 2020.
7
Larva Extract Ameliorates the Hepatic Insulin Resistance of High-Fat Diet-Induced Diabetic Mice.幼虫提取物可改善高脂饮食诱导的糖尿病小鼠的肝胰岛素抵抗。
Nutrients. 2019 Jul 4;11(7):1522. doi: 10.3390/nu11071522.
8
Prediction of VEGF-C as a Key Target of Pure Total Flavonoids From Citrus Against NAFLD in Mice via Network Pharmacology.基于网络药理学预测柑橘纯总黄酮抗小鼠非酒精性脂肪性肝病的关键靶点血管内皮生长因子C
Front Pharmacol. 2019 Jun 4;10:582. doi: 10.3389/fphar.2019.00582. eCollection 2019.
9
A Metabolomic Study on the Intervention of Traditional Chinese Medicine Qushi Huayu Decoction on Rat Model of Fatty Liver Induced by High-Fat Diet.基于代谢组学的中药祛瘀化痰方对高脂饮食诱导大鼠脂肪肝干预作用的研究。
Biomed Res Int. 2019 Feb 7;2019:5920485. doi: 10.1155/2019/5920485. eCollection 2019.
10
Herbal Extracts and Natural Products in Alleviating Non-alcoholic Fatty Liver Disease via Activating Autophagy.通过激活自噬来缓解非酒精性脂肪性肝病的草药提取物和天然产物
Front Pharmacol. 2018 Dec 11;9:1459. doi: 10.3389/fphar.2018.01459. eCollection 2018.